Wuhan Kangdeqing Biotechnology Co., Ltd.

Wuhan Kangdeqing Biotechnology Co., Ltd. is located in Wuhan Optics Valley Biopolis, dedicated to the fields of in vitro diagnostic reagents, medical instruments, and biotherapy. Its systems cover production lines for enzyme-linked immunosorbent assay, colloidal gold, chemiluminescence, molecular diagnostics, etc. Its products cover multiple fields such as infectious diseases and tumor screening. It currently has more than 10 product approval numbers including national drug approval numbers, and owns multiple independent intellectual property rights. The company adheres to the corporate spirit of "social responsibility, integrity, unity and pragmatism, innovation and enterprise", emphasizes people-oriented values, is rooted in Optics Valley, and is committed to building "Kangdeqing Biotechnology" into a biopharmaceutical high-tech enterprise at the international advanced level.

Company scale:
A high-tech enterprise focusing on diagnostic reagents and integrating R&D, production, and operation;
*** batch passed the GMP certification of the State Food and Drug Administration;
A production base covering an area of 30 mu;
5,000 square meters of standard factory buildings in Optics Valley Biopolis.

Company qualifications:
Drug Production License
Medical Device Production License
Medical Device Business License
It has a complete quality management system for in vitro diagnostic reagents, covering colloidal gold method, latex method, enzyme-linked immunosorbent assay method, and chemical method product lines, and has passed the on-site system assessment of the State Food and Drug Administration.

Honors received:
Chinese Academy of Sciences Biotechnology Innovation Fund
Optics Valley Biopolis 5th Batch 3551 Fund
Biotechnology Innovation Fund
Hubei Province Technology-based SME Technological Innovation Fund Non-reimbursable Assistance Project
More than ten patents